Back Policy/Litigation
Back Resolutions
Back Current Initiatives
Back Donate
Default image for pages

Investors cite concerns, including recent funding freezes, exits from global health bodies, and appointment of unqualified officials that may threaten equitable access to healthcare.

NEW YORK, NY, THURSDAY, APRIL 17, 2025 – Members of the Interfaith Center on Corporate Responsibility today announced they had issued a public statement calling on corporations to champion policies that protect and advance public health.

ICCR members have long engaged with leading healthcare companies to advocate for access to and affordability of medicines, vaccines, nutrition, and health technologies, especially for populations that have been systematically marginalized. Their statement today was driven by the administration’s recent funding freezes, departures from global health organizations, and the appointment of unqualified officials to lead key national public health institutions – actions that investors argue threaten public health both within the U.S. and worldwide.

Their statement asks companies to take four key steps: ensure that their political activities and public policy engagements support the advancement of global public health; assess the impacts of their businesses on the human right to health; adopt policies and processes that ensure the right to health is upheld within their operations; and support the appointment of individuals with appropriate experience to lead key U.S. public health positions. 

“The defunding, dismantling, and abandonment of structures and initiatives that undergird public health systems both domestically and globally should concern every business,” said Lydia Kuykendal, Director of Shareholder Advocacy for Mercy Investment Services. “These actions and policies will have direct and long-lasting consequences for company prosperity through the diminished health of their workforces and indirectly, through diminished public health that will create broader and persistent economic burdens.”

The investors are particularly concerned by the dismantling of the United States Agency for International Development (USAID), a dramatic move expected to broadly jeopardize global health and national security, while also costing U.S. businesses, universities, and farmers an estimated $28.9 billion in funding.

Investors also questioned the U.S.’s withdrawal from the World Health Organization (WHO), a move that is widely expected to destabilize global health systems at a time when international cooperation is most needed to solve emerging health threats, such as Monkeypox and avian influenza. Also of concern is the dismantling of the U.S. President’s Emergency Plan for Aids Relief (PEPFAR), a decision widely expected to result in an increase in global AIDS-related deaths and new HIV infections.

“As long-term institutional investors, we view robust public health systems as critical to a thriving economy and the security of our portfolios,” said Amy Carr, Senior Shareholder Advocate for Friends Fiduciary. “We call on businesses to use their influence to demonstrate their support for their workers, suppliers, customers, and investors by standing up for their right to health.”

The investor statement also addressed recent staffing decisions by the administration, including mass layoffs and the placement of personnel with inadequate training and expertise to lead key government healthcare agencies.

The U.S. Department of Health and Human Services (HHS) houses the largest research enterprise in the world, the National Institutes of Health, the Centers for Disease Control and Prevention, and the Food and Drug Administration, and manages the Centers for Medicare and Medicaid Services (CMS). The Department’s work in disease prevention, healthcare delivery, research, drug development, and food safety is relied upon daily by every U.S. citizen and every business.

“The U.S. Department of Health and Human Services (HHS) oversees vital public health programs and is a pivotal U.S. agency,” said Meg Jones-Monteiro, ICCR’s Senior Director – Health Equity and Evaluation.  “To fulfill its mandate to protect public health and foster economic stability, HHS must be staffed by only the most qualified and credentialed candidates and its policies must remain grounded in robust and impartial research and sound science that is thoroughly vetted.”

In their statement, the investors affirmed affordable and equitable healthcare not just as a human right, but a moral imperative and an economic necessity essential to the well-being of citizens, the workforce, and a thriving economy.  

About the Interfaith Center on Corporate Responsibility (ICCR)
The Interfaith Center on Corporate Responsibility (ICCR) is a broad coalition of more than 300 institutional investors collectively representing over $4 trillion in invested capital. ICCR members, a cross-section of faith-based investors, asset managers, pension funds, foundations, and other long-term institutional investors, have over 50 years of experience engaging with companies on environmental, social, and governance (“ESG”) issues that are critical to long-term value creation.  ICCR members engage hundreds of corporations annually in an effort to foster greater corporate accountability. Visit our website www.iccr.org and follow us on  LinkedIn, Bsky and X.

UnitedHealth Group is the latest company to utilise new guidance, as shareholders figure out their shifting rights.

The faith-based shareholders’ proposal was challenged by UnitedHealth twice, thanks to a recent SEC guidance change the shareholders slammed as unfair.

A group of UnitedHealth Group shareholders is withdrawing a proposal submitted for the 2025 proxy that requested the company’s management analyze how its business practices affect access to care and public health.

NEW YORK, NY, THURSDAY, April 4, 2025 – Shareholders of UnitedHealth Group ($UNH) today announced their withdrawal of a proposal submitted for the 2025 proxy after facing a series of challenges from the company at the Securities and Exchange Commission (SEC).

The proposal filed by the Congregation des Soeurs des Saints Noms de Jesus et de Marie requested that UNH’s Board of Directors prepare a report on the public health-related costs and macroeconomic risks associated with the company’s practices that limit or delay access to healthcare. Proponents argued that short-sighted company policies and practices aimed at delaying and denying coverage to policyholders create longer-term economic burdens that adversely affect both the company and investors’ total portfolios by increasing consumer debt, deteriorating public health, and reducing workforce productivity, which strains government resources.

In recent years, UNH has attracted the scrutiny of lawmakers and regulators who have sharply criticized the company for its market dominance and conflicts, given its control of both providers and insurers, excessive profiteering within its Medicare Advantage business, and allegedly using an error-prone algorithm to systematically deny care to older Americans. It is also facing a federal antitrust investigation and a Justice Department lawsuit seeking to block its proposed acquisition of the home health provider Amedisys.

The proposal was set to go to a vote of company shareholders at UNH’s spring annual meeting when the company submitted its “no-action” request to the SEC, which would allow it to omit the proposal from its proxy. As the proponents were in dialogue with the company, the SEC unexpectedly issued new guidance in a mid-season Staff Legal Bulletin (SLB 14M), creating a loophole that permitted the company to file a second and additional no-action request. To avoid jeopardizing the chance to re-file the proposal next year, the proponents made the difficult decision to withdraw the proposal this year.

Said lead filer Timnit Ghermay, “Applying new guidance to previously submitted proposals in this manner unfairly penalizes investors who have followed the SEC’s guidance in good faith. The 14M Bulletin and UNH’s challenge disenfranchise investors of their rights to put forward questions of material risk to their fellow shareholders. Our proposal requested much-needed circumspection by the board and management to consider the systemic risks created by denial and delaying care for policyholders. As long-term shareholders invested in the success of our company and reliant on a healthy economy, we fully intend to keep this issue in front of the company in our upcoming dialogues.”

CONTACT:
Susana McDermott
Director of Communications
Interfaith Center on Corporate Responsibility (ICCR)
201-417-9060 (mobile)
smcdermott@iccr.org 

About the Interfaith Center on Corporate Responsibility (ICCR) 
The Interfaith Center on Corporate Responsibility (ICCR) is a broad coalition of more than 300 institutional investors collectively representing over $4 trillion in invested capital. ICCR members, a cross-section of faith-based investors, asset managers, pension funds, foundations, and other long-term institutional investors, have over 50 years of experience engaging with companies on environmental, social, and governance (“ESG”) issues that are critical to long-term value creation.  ICCR members engage hundreds of corporations annually in an effort to foster greater corporate accountability. Visit our website www.iccr.org and follow us on LinkedInBsky and X.

ICCR has been publishing the Proxy Resolutions and Voting Guide annually since 1974 as a way to educate and build support for member proposals. In our Guide, you will find all ICCR member-sponsored proposals for 2025 corporate proxies along with a preliminary overview of the proxy season and short features from proponents about their engagements on key environmental and social issues. Please feel free to share this resource widely with your networks. And, if you are an investor, we urge you to exercise your shareholder rights by voting your proxies.

Download our 2025 Guide here.

Download the launch webinar slide deck here.

UnitedHealth Group is attempting to swat down a non-binding shareholder proposal that asked the company to prepare reports on the costs of delayed and denied healthcare.

UnitedHealth Group in the cross-hairs—not by patients and regulators but shareholders. … On Wednesday, UHG shareholders requested the company prepare a report on the costs and public health impact related to UnitedHealth’s practices that limit or delay access to healthcare.

ATA urges nine telehealth priorities for the Trump Administration’s consideration. Acknowledging that HHS expanded Medicare telehealth flexibilities at the start of the pandemic in 2020 in the previous Trump Administration, the American Telemedicine Association’s list is long and detailed.